The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
Hospitals participating in the Inpatient Quality Reporting and/or Promoting Interoperability Programs must submit data for at least four electronic clinical…
Headline
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology and Centers for Medicare…
Headline
In a commentary published Saturday in Modern Healthcare, AHA President and CEO Rick Pollack and Federation of American Hospitals President and CEO Chip Kahn…
Headline
The Senate Health, Education, Labor & Pensions Committee today held a hearing to examine how primary care affects health care costs and outcomes.
Headline
The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain…
Headline
Hospitals participating in the Inpatient Quality Reporting and/or Promoting Interoperability Programs must submit data for at least four electronic clinical…